MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Solid Biosciences Inc. (NASDAQ:SLDB)*
Organization & Developments: Solid Biosciences
Parents
Solid Biosciences Inc. (NASDAQ:SLDB)*
Children
2018: FDA slaps a clinical hold on Solid Bio’s gene therapy for Duchenne MD in wake of safety alert
2018: Solid Biosciences: Initiating Coverage With A Sell Rating And First Price Target Of $18_seekingalpha.com
2019: FDA puts Solid Bio’s lead gene therapy program on hold
2019: Solid to soldier on as initial muscular dystrophy results disappoint
2020: Controversial Duchenne MD player Solid Bio takes another hit, laying off staffers in a bid to weather FDA hold – Endpoints News
2022: Solid Biosciences (SLDB) Investor Presentation - Slideshow_seekingalpha.com
2022: Solid Biosciences lays off 35% of workforce, chief operating officer exits
2024: Buy Solid Biosciences: Unpacking Its Main Value Drive
2024: Buy Solid Biosciences: Unpacking Its Main Value Driver
2024: Solid Biosciences: DMD Treatment Advancement With Next-Generation Capsid_ seekingalpha.com
2025: Solid Bio surges after trial data for lead asset in Duchenne_ seekingalpha.com
2025: Solid Biosciences: Differentiating Factors Of SGT-212 To Set Itself Apart_ seekingalpha.com
2026: Solid Biosciences: Positive FDA Meeting SGT-003 Sets Up Next Milestones (NASDAQ:SLDB)
Jumps
*Key People: Solid Biosciences
Finance & Acquisitions: Solid Biosciences